Webster H K, Boudreau E F, Pavanand K, Yongvanitchit K, Pang L W
Am J Trop Med Hyg. 1985 Mar;34(2):228-35. doi: 10.4269/ajtmh.1985.34.228.
Antimalarial activity of chloroquine, quinine, mefloquine and halofantrine against 33 strains of P. falciparum isolated from naturally acquired malaria infections in Thailand was determined using a radioisotope microdilution method. A microtitration procedure was used to test isolates of P. falciparum against the 4 drugs simultaneously. The mean ID50 for chloroquine and quinine reflected known resistance to those drugs in Thailand. The mean ID50 for mefloquine and halofantrine showed susceptibility to these drugs. Four isolates of P. falciparum however had markedly decreased susceptibility to mefloquine (ID50 greater than 15 ng/ml); one case of which was confirmed as the first case of RII resistance for mefloquine in Thailand. Several parasite isolates were also observed to have decreased susceptibility to the new drug, halofantrine. These studies strongly recommend that in vitro testing be done in conjunction with field evaluation of new antimalarial drugs.
采用放射性同位素微量稀释法,测定了氯喹、奎宁、甲氟喹和卤泛群对从泰国自然感染疟疾中分离出的33株恶性疟原虫的抗疟活性。采用微量滴定程序同时检测恶性疟原虫分离株对这4种药物的敏感性。氯喹和奎宁的半数抑制浓度(ID50)均值反映了泰国对这些药物已知的耐药性情况。甲氟喹和卤泛群的ID50均值显示这些药物的敏感性。然而,4株恶性疟原虫分离株对甲氟喹的敏感性显著降低(ID50大于15纳克/毫升);其中1例被确认为泰国首例甲氟喹RII耐药病例。还观察到几株寄生虫分离株对新药卤泛群的敏感性降低。这些研究强烈建议,在对新抗疟药物进行现场评估的同时,开展体外检测。